IGF2BP3 and neoplasm: Notably, both IGF2BP3 and PDPN expression was shown to correlate with lymph node metastasis in OSCC patients and IGF2BP3 downregulation inhibited invadopodia formation, extracellular matrix degradation, and tumor growth and invasiveness [148,154].